400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / mGluR / ML289
CAS No.: 1382481-79-9
Synonyms: VU0463597
ML 289 is a selective negative allosteric modulator at mGlu3 receptors with IC50 of 660 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02212106 | - | - | Completed | - | - |
NCT00947882 | Lower Urinary Tract Symptoms (... more >>LUTS) Collapse << | Phase 2 | Completed | - | - |
NCT00947882 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 1382481-79-9 | 储存条件 |
|
|
分子式 | C22H23NO3 | 运输 | 蓝冰 | |
分子量 | 349.42 | 别名 | VU0463597 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02212106 | - | - | Completed | - | - |
NCT00947882 | Lower Urinary Tract Symptoms (... more >>LUTS) Collapse << | Phase 2 | Completed | - | - |
NCT00947882 | - | - | Completed | - | - |
NCT02212106 | Influenza, Human | Phase 4 | Completed | - | United States, California ... more >> Site 286 Los Angeles, California, United States, 90036 United States, Idaho Site 289 Boise, Idaho, United States, 83642 United States, Missouri Site 287 Saint Louis, Missouri, United States, 63141 United States, New York Site 285 Binghamton, New York, United States, 13901 United States, North Carolina Site 290 Durham, North Carolina, United States, 27704 Site 281 Raleigh, North Carolina, United States, 27609 Site 280 Winston-Salem, North Carolina, United States, 27103 United States, South Carolina Site 284 Charleston, South Carolina, United States, 29403 United States, Texas Site 283 Austin, Texas, United States, 78705 Site 282 Fort Worth, Texas, United States, 76135 Site 288 San Angelo, Texas, United States, 76904 Collapse << |
NCT01421511 | Skin and Subcutaneous Tissue B... more >>acterial Infections Collapse << | Phase 3 | Completed | - | - |
NCT00552344 | Crohn Disease | Phase 3 | Completed | - | - |
NCT02545543 | Influenza, Human | Phase 3 | Completed | - | - |
NCT01421511 | - | - | Completed | - | - |
NCT02545543 | - | - | Completed | - | - |
NCT00262522 | Human Immunodeficiency Virus I... more >>nfections Collapse << | Phase 3 | Completed | - | - |
NCT02214225 | - | - | Completed | - | - |
NCT00552344 | - | - | Completed | - | - |
NCT02154594 | Gingivitis | Phase 4 | Completed | - | India ... more >> Tatyasaheb Kore Dental College and Research Centre Kolhapur, Maharashtra, India, 416 137 Collapse << |
NCT00262522 | - | - | Completed | - | - |
NCT03697629 | Multiple Myeloma in Relapse | Phase 2 | Not yet recruiting | February 2020 | - |
NCT00024934 | IgA Deficiency | Phase 1 | Completed | - | United States, Maryland ... more >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Collapse << |
NCT01922856 | Enteritis; Escherichia Coli, E... more >>nterotoxigenic Collapse << | Phase 2 | Completed | - | United States, Maryland ... more >> Johns Hopkins Center for Immunization Research Baltimore, Maryland, United States, 21205 Naval Medical Research Center Silver Spring, Maryland, United States, 20910 Collapse << |
NCT02897648 | - | - | Recruiting | May 31, 2019 | France ... more >> Groupe Hospitalier Paris Saint Joseph Recruiting Paris, Ile-de-France, France, 75014 Contact: BEAUSSIER Helene, PhD, PharmD +33 1 44 12 70 38 hbeaussier@hpsj.fr Contact: Mohamed CHERIFI, PharmD +33 1 44 12 70 84 mcherifi@hpsj.fr Collapse << |
NCT02255812 | Exploratory Behavior | Not Applicable | Completed | - | Switzerland ... more >> University Hospital Basel, Switzerland, CH-4031 Collapse << |
NCT02214225 | Influenza, Human | Phase 3 | Completed | - | - |
NCT02755532 | Pharmacokinetics ... more >> Anesthetics, Local Collapse << | Not Applicable | Completed | - | - |
NCT02121119 | Hallux Valgus | Phase 4 | Completed | - | Chile ... more >> División de Anestesia - Facultad de Medicina Pontificia Universidad Católica Santiago, Región Metropolitana, Chile, 8330024 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网